| Primary |
| Hypertension |
27.1% |
| Atrial Fibrillation |
13.6% |
| Medical Diet |
10.2% |
| Diabetes Mellitus |
6.8% |
| Acute Coronary Syndrome |
5.1% |
| Cardiac Failure Congestive |
5.1% |
| Rheumatoid Arthritis |
5.1% |
| Thrombosis Prophylaxis |
5.1% |
| Pyelonephritis |
3.4% |
| Angina Pectoris |
1.7% |
| Arrhythmia |
1.7% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Cardiac Failure |
1.7% |
| Migraine |
1.7% |
| Migraine Prophylaxis |
1.7% |
| Oesophagitis |
1.7% |
| Palpitations |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Thrombophlebitis |
1.7% |
| Wound Infection |
1.7% |
|
| Dyspnoea Exertional |
13.0% |
| Tibia Fracture |
13.0% |
| Quality Of Life Decreased |
8.7% |
| Aptyalism |
4.3% |
| Cough |
4.3% |
| Drug Interaction |
4.3% |
| Headache |
4.3% |
| Heart Rate Decreased |
4.3% |
| Intestinal Dilatation |
4.3% |
| Malaise |
4.3% |
| Myoglobin Blood Increased |
4.3% |
| Nausea |
4.3% |
| Polyneuropathy |
4.3% |
| Psoriatic Arthropathy |
4.3% |
| Saliva Altered |
4.3% |
| Syncope |
4.3% |
| Trismus |
4.3% |
| Visual Impairment |
4.3% |
|
| Secondary |
| Depression |
25.5% |
| Hypertension |
16.3% |
| Product Used For Unknown Indication |
13.3% |
| Atrial Fibrillation |
8.7% |
| Arrhythmia |
5.6% |
| Drug Use For Unknown Indication |
5.6% |
| Wound Infection |
5.1% |
| Thrombophlebitis |
4.6% |
| Medical Diet |
3.1% |
| Diabetes Mellitus |
2.0% |
| Cardiac Failure Congestive |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
| Acute Myocardial Infarction |
1.0% |
| Migraine |
1.0% |
| Migraine Prophylaxis |
1.0% |
| Neck Injury |
1.0% |
| Drug Use For Unknown Indication |
0.5% |
| Wound Infection |
0.5% |
| Angina Pectoris |
0.5% |
|
| Myoglobin Blood Increased |
18.6% |
| Growth Retardation |
9.3% |
| Circulatory Collapse |
7.0% |
| Foetal Growth Retardation |
7.0% |
| Syncope |
7.0% |
| Tibia Fracture |
7.0% |
| Cerebral Ventricle Dilatation |
4.7% |
| Foetal Growth Restriction |
4.7% |
| Headache |
4.7% |
| Tricuspid Valve Incompetence |
4.7% |
| Trismus |
4.7% |
| Drug Exposure During Pregnancy |
2.3% |
| Head Circumference Abnormal |
2.3% |
| Malaise |
2.3% |
| Nausea |
2.3% |
| Quality Of Life Decreased |
2.3% |
| Rhabdomyolysis |
2.3% |
| Saliva Altered |
2.3% |
| Therapeutic Agent Toxicity |
2.3% |
| Urticaria |
2.3% |
|
| Concomitant |
| Hypertension |
18.5% |
| Product Used For Unknown Indication |
18.3% |
| Hypercholesterolaemia |
9.0% |
| Drug Use For Unknown Indication |
7.8% |
| Rheumatoid Arthritis |
6.2% |
| Atrial Fibrillation |
5.2% |
| Pain |
3.9% |
| Surgery |
3.9% |
| Anticoagulant Therapy |
3.5% |
| Depression |
3.3% |
| Diabetes Mellitus |
3.0% |
| Cardiac Failure |
2.9% |
| Osteoporosis |
2.1% |
| Coronary Artery Disease |
2.0% |
| Prophylaxis |
2.0% |
| Thrombosis Prophylaxis |
1.9% |
| Angina Pectoris |
1.6% |
| Heart Transplant |
1.6% |
| Hypothyroidism |
1.6% |
| Stent Placement |
1.6% |
|
| Vomiting |
11.4% |
| Interstitial Lung Disease |
7.0% |
| Nervous System Disorder |
7.0% |
| Rhabdomyolysis |
7.0% |
| Nephrogenic Systemic Fibrosis |
6.1% |
| Pruritus |
6.1% |
| Pyrexia |
5.3% |
| Sepsis |
5.3% |
| Renal Failure Acute |
4.4% |
| Tooth Extraction |
4.4% |
| Urinary Tract Infection |
4.4% |
| Wheezing |
4.4% |
| Headache |
3.5% |
| Renal Failure |
3.5% |
| Renal Impairment |
3.5% |
| Subileus |
3.5% |
| Tremor |
3.5% |
| Weight Increased |
3.5% |
| Wound Drainage |
3.5% |
| Clear Cell Carcinoma Of The Kidney |
2.6% |
|
| Interacting |
| Atrial Fibrillation |
56.3% |
| Hypertension |
34.4% |
| Cardiac Failure |
9.4% |
|
| Dyspnoea |
44.4% |
| Drug Interaction |
22.2% |
| Circulatory Collapse |
11.1% |
| Sudden Death |
11.1% |
| Tricuspid Valve Incompetence |
11.1% |
|
